{"name":"In8bio Inc.","slug":"in8bio-inc","ticker":"","exchange":"","domain":"in8bio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxOS3MyV0FRRnBrZlB4QnhIa0RoejBZd001MVdJdGJsSGZuSnZYR004RTJOOUlueDRQLXk1Q3owMkZNX09iOElPXzA0clFGbnotQWQwTDVfOTE4c1lnbjZnZjdFUURZaUdZWk14S1ZjM2hOczZ3X1hMQjkwTnVsb19BRFNUOUk4ekg3WExUeWFJa2ZFSXV0RzRNUGh3aHVuby1zSXIxQlVZdVJQM0tzZE0tMml5RjQ5bVFsS1FoR2FOOEs4c211QXhzMGltZVlaZWpfNzVTYmhHbVBXS2NGRE9jSUlQRS11TVU2LXlTMjNVQVNXZzBiNzlKNlhPN3dIUzlDZEFmSUJQLWh3a2FIalZTc2VR?oc=5","date":"2026-04-07","type":"pipeline","source":"ChartMill","summary":"RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms - ChartMill","headline":"RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQZVhydUw3eXNQTE1DWExaRllrb2xiam55U1oxUjIwYmRxMTExWFdfcEhSMWU2OHFwNm9Cai0yX0w5eUZrbjRiM2ZabERTSGViZkdKY3ctNGE0SmJxdmlyNEkzSXUxS2I5cnVna2ZoZVVudWdBODR2RUJrcUVOcEVYT0d4enFWZEhEdE9EYlJZRkw4ZGw1TmxVTTdvRC1IM3lIQklVRXlRT1VWUGpPX0RBZlF5VXBFMDN6ZVpCbU00aUF6amVMbkVmcHlZVEp4VXIzWWZNag?oc=5","date":"2026-04-03","type":"pipeline","source":"GlobeNewswire","summary":"IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire","headline":"IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNa1lJY0Jubm1ydm1iMkJUelhNY2RWaHF4dzdmWUxFT3RDTjh3dzJ5enQtSDB3M2Y0SHBjYlA2dDlSR3otMkhJNmg2ZEFTTFJkU2JJUkdpdkdnMm9rTk1hZHN4QXZidUdwQ1BEbW9tMTMyTXR4VThkVnhMZnI1TDE1WGp1RmhpNll3SWh4WHNJUlVPSEllMXJybE9Fa1lNRXhlLWFRS0dUeDFrdDQ?oc=5","date":"2026-03-26","type":"regulatory","source":"Stock Titan","summary":"IN8bio (NASDAQ: INAB) seeks approval of 2026 equity incentive plan at virtual meeting - Stock Titan","headline":"IN8bio (NASDAQ: INAB) seeks approval of 2026 equity incentive plan at virtual meeting","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPbXY1cTBPV0x5ZHhIdHJES083MkN2WFZtZlpQSk9HQU1GZUVuc3NVZ25NaFVBY1E0TVVER2dnVHl1dHQ0cGpneGI1Rk1xbjNhZWVxdklrNWxCeW9pR3dFYnVKV0k4TnZCRWZnRE1uWlJieFZFTXNTRG1KS3JyZTNjdFllc3JqUG8?oc=5","date":"2026-02-13","type":"pipeline","source":"Fierce Biotech","summary":"Sanofi’s stunning CEO switch—Chutes & Ladders - Fierce Biotech","headline":"Sanofi’s stunning CEO switch—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5XWTRObnZEVTlMZllqUnJuTDFvTFkwd0FZWEJkekxtSWhTeUU2bjFBdjlkTXBDVzEzamdYbmM1S2JRMWZ2U1o5RnBQN0NsdVIyMFJwN09SLWJMX091SkhleEJ1Z1JYYm1rbUUwSENrNVQ?oc=5","date":"2025-12-19","type":"pipeline","source":"StocksToTrade","summary":"IN8bio Inc. Stock Surge: Decoding the Unexpected​ - StocksToTrade","headline":"IN8bio Inc. Stock Surge: Decoding the Unexpected​","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9wX284S0ZtRkZscXQtR0RQMGdlVVBYU2MxYTZVeU9JY3pldTIwenJsZnpSSmc0bVNQWWdBZ3FLVHdXQ25wRzd6MkJoVXQzLWZUWWtN?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"INAB Stock Price, News & Analysis | In8Bio - Stock Titan","headline":"INAB Stock Price, News & Analysis | In8Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBBWU81NENQTWtIcVJNV1VIZUlBdGZxNG5faVNFaHhIS1BNRm92S0JYYlZYUEFwMERzU2lIbWFXR3dPU1dvMlBJQlpBNXdCM1UxSGoxM2J3TjlpRlZQTzYzTmRDNTJJbFRSTHFGdUoyR3ZfbmlfelJOcUln?oc=5","date":"2025-03-05","type":"trial","source":"Oncology Pipeline","summary":"T-cell engagement with a difference | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"T-cell engagement with a difference | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNaVRSbjFYLUhnNFRQVjBzcEpYTXlReWx6ZVVRNFNWZFpwYmdpbjF5OFFQZzRNYnNrbkhlRElIWWZkTVBZS09PRm0wa0FWMUlEUEtZZTV4T2F1TUZzM2o4MkttRk5JNFdQQmwtT2UtMTZ3NGU3V1ZYVVZWQ2hiRUlnX1ZuWm51eHUzckFYakJnc0FFOG01cXBJUUhmdUxNRjVEMHpqaERKbGxGNl9CQUF1NW5MMVRyQzRwVzZ2RWFOWQ?oc=5","date":"2024-10-01","type":"pipeline","source":"BioSpectrum Asia","summary":"Biopharma Giants Face Industry-Wide Layoffs Amid Economic Pressures - BioSpectrum Asia","headline":"Biopharma Giants Face Industry-Wide Layoffs Amid Economic Pressures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQOE5JZVowU29TUGVPa0JPZ0NZN3FBRVh5QjJGRUwwYmd6Wk85S29sTjFCV0pOeWROWmdLa2I5a3lvS1IwbmloNkxycVJxdlJOR3UxcnpGTWpLSmR4a1RPTUNILTBKRFc3NnRmTzdpWU12cjRYcmdhcjRrTFMySWljWkZOTUZqRGdsNG5iSDlrUl9rWEJJU3FYNjMwMC1ONkhWQUxURUhRc3k1Tk5iV0dweFIzYW51NVlzUmNpclpWam03a25RSUE?oc=5","date":"2024-09-05","type":"trial","source":"Fierce Biotech","summary":"IN8bio halts phase 2 glioblastoma trial, lays off half of workforce to focus on leukemia cell therapy - Fierce Biotech","headline":"IN8bio halts phase 2 glioblastoma trial, lays off half of workforce to focus on leukemia cell therapy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1sbWtKdXl1TG9lakF3Q3NnaXVhUk1fcXlwWFZYakN0NjRIVlJaYm1aM2hXcndxMHV4Ujd1b1c3eFZEMjl5QjRrTXRjVWVPV091LU5mNlYxWEoxRTRTUXVwTFBsejQxS2dDRTUzcUl4RS0xNUo1V2hiWkozVW54SVE?oc=5","date":"2024-03-02","type":"pipeline","source":"PharmTech.com","summary":"Development of Gamma-Delta T-Cell Therapies - PharmTech.com","headline":"Development of Gamma-Delta T-Cell Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPcW90c29tV3NKSlJ1cmM1b3hCQ2I1ODZiVnpZc0RCSF9kRERIN3NVbktTaXZxTk5zNkdTZXo0X0dsSElyOGVzTEJBWkNsd1VWN3RQQWlCejFGOVpLanhIT1I3R2FfVm9maU1ZamhYTWZZLTVYclhac1gxVzZQOEVvQU5XdmR6bWlWYWxMNEh3XzFGUnI0c2RyLTZ3dWd1NVBCTktkRnhNeGRJYlV6V0pnTS1RY2pmQXE1YndiZHV6ZGl2bFdzVExIZmJTRTFHZw?oc=5","date":"2022-09-19","type":"deal","source":"UofLNews","summary":"IN8bio partners with UofL's Dunbar CAR T-Cell Program as the Manufacturing Center for INB-400 - UofLNews","headline":"IN8bio partners with UofL's Dunbar CAR T-Cell Program as the Manufacturing Center for INB-400","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOUm1ndS00bWd2dE4tS2FHZzR4VE1JWEhIUHVKWU82cE5nSW9xa242ek5mSTJSbndjY2tXdVVxeEZ0cHFIYWJRcE9RRFBKd0J3V3lRU1R3STE4RnBSWG5UelFzWUZyMWhHZndSNXhfc05OX2tIZFBacGQ2QXNycEpPRWgwOU85X0xWQUhTLTB4eFlvd0VuVkZxVDhrTjlnYzd3RUZib2t6RTBwQ1k?oc=5","date":"2022-07-12","type":"pipeline","source":"citybiz","summary":"IN8bio Appoints Kenneth LaMontagne, Ph.D., to Lead Business Development - citybiz","headline":"IN8bio Appoints Kenneth LaMontagne, Ph.D., to Lead Business Development","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":9,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}